Ghodrat Montazeri

Summary

Affiliation: Tehran University of Medical Sciences
Country: Iran

Publications

  1. ncbi The role of mutations in core protein of hepatitis B virus in liver fibrosis
    Ashraf Mohamadkhani
    National Institute of Genetic Engineering and Biotechnology Tehran, Iran
    Virol J 6:209. 2009
  2. ncbi Liver histology and HBV DNA levels in chronically HBV infected patients with persistently normal alanine aminotransferase
    Ghodrate Montazeri
    Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Arch Iran Med 13:193-202. 2010
  3. ncbi Surface area: a better predictor of disease severity than the height and volume of the barium column in patients with primary achalasia
    Ghodrat Montazeri
    Digestive Disease Research Center, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran
    Eur J Gastroenterol Hepatol 18:1203-8. 2006
  4. ncbi Current treatment of chronic hepatitis B
    Ghodrat Montazeri
    Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Arch Iran Med 9:1-10. 2006
  5. ncbi Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B
    Ghodrat Montazeri
    Digestive Disease Research Centre, Tehran University of Medical Science, Tehran, Iran
    BMC Gastroenterol 5:32. 2005
  6. ncbi Lower oesophageal sphincter pressure and timed barium oesophagogram: two objective parameters in the non-invasive assessment of primary achalasia
    G Montazeri
    Gastroenterology and Hepatology, Digestive Disease Research Center, Tehran University of Medical Science, Shariati Hospital, Tehran, Iran
    Aliment Pharmacol Ther 22:261-5. 2005
  7. ncbi Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease
    Mehdi Mohamadnejad
    Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Am J Gastroenterol 101:2537-45. 2006
  8. ncbi Injection of botulinum toxin before pneumatic dilatation in achalasia treatment: a randomized-controlled trial
    J Mikaeli
    Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Aliment Pharmacol Ther 24:983-9. 2006
  9. ncbi Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia
    J Mikaeli
    Digestive Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Aliment Pharmacol Ther 15:1389-96. 2001
  10. ncbi Efficacy of botulinum toxin injection before pneumatic dilatation in patients with idiopathic achalasia
    J Mikaeli
    Achalasia Research Unit, Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Dis Esophagus 17:213-7. 2004

Collaborators

Detail Information

Publications11

  1. ncbi The role of mutations in core protein of hepatitis B virus in liver fibrosis
    Ashraf Mohamadkhani
    National Institute of Genetic Engineering and Biotechnology Tehran, Iran
    Virol J 6:209. 2009
    ..Our data suggests that core protein mutations in CTL epitopes and C-terminal domain accompanied with higher stage of liver fibrosis may be due to alterations in the function of core protein...
  2. ncbi Liver histology and HBV DNA levels in chronically HBV infected patients with persistently normal alanine aminotransferase
    Ghodrate Montazeri
    Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Arch Iran Med 13:193-202. 2010
    ..We aimed to investigate the histological activity and HBV DNA levels in these patients...
  3. ncbi Surface area: a better predictor of disease severity than the height and volume of the barium column in patients with primary achalasia
    Ghodrat Montazeri
    Digestive Disease Research Center, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran
    Eur J Gastroenterol Hepatol 18:1203-8. 2006
    ..Subjective assessment of primary achalasia is not accurate. We aimed to study the utility of surface area of barium retention in the objective assessment of these patients...
  4. ncbi Current treatment of chronic hepatitis B
    Ghodrat Montazeri
    Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Arch Iran Med 9:1-10. 2006
    ..Treatment strategy is changing towards using prolonged combination therapy with evolving nucleoside analogues with or without an immunomodulatory agent, aiming at eradicating covalently closed circular DNA...
  5. ncbi Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B
    Ghodrat Montazeri
    Digestive Disease Research Centre, Tehran University of Medical Science, Tehran, Iran
    BMC Gastroenterol 5:32. 2005
    ..It is crucial to monitor this disease more closely with a non-invasive marker in clinical trials. We aimed to evaluate the predictive value of serum hyaluronate for the presence of extensive liver fibrosis and inflammation...
  6. ncbi Lower oesophageal sphincter pressure and timed barium oesophagogram: two objective parameters in the non-invasive assessment of primary achalasia
    G Montazeri
    Gastroenterology and Hepatology, Digestive Disease Research Center, Tehran University of Medical Science, Shariati Hospital, Tehran, Iran
    Aliment Pharmacol Ther 22:261-5. 2005
    ..The non-invasive assessment of primary achalasia is not precise...
  7. ncbi Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease
    Mehdi Mohamadnejad
    Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Am J Gastroenterol 101:2537-45. 2006
    ..87. CONCLUSIONS: Significant hepatic fibrosis and necroinflammation can reliably be predicted using routinely checked tests and HBV DNA levels...
  8. ncbi Injection of botulinum toxin before pneumatic dilatation in achalasia treatment: a randomized-controlled trial
    J Mikaeli
    Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Aliment Pharmacol Ther 24:983-9. 2006
    ..07). CONCLUSION: Injection of botulinum toxin before pneumatic dilatation does not significantly enhance the efficacy of pneumatic dilatation...
  9. ncbi Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia
    J Mikaeli
    Digestive Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Aliment Pharmacol Ther 15:1389-96. 2001
    ..The efficacy of a single pneumatic dilatation is similar to that of two botulinum toxin injections...
  10. ncbi Efficacy of botulinum toxin injection before pneumatic dilatation in patients with idiopathic achalasia
    J Mikaeli
    Achalasia Research Unit, Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
    Dis Esophagus 17:213-7. 2004
    ..It seems that BT may be a meaningful enhancing factor in long-term efficacy of PD. PD with a 30 mm balloon after a BT session may resolve the need for the future higher grade PD...
  11. ncbi Pneumatic balloon dilatation in achalasia: a prospective comparison of safety and efficacy with different balloon diameters
    J Mikaeli
    Digestive Disease Research Centre (DDRC, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
    Aliment Pharmacol Ther 20:431-6. 2004
    ..The duration of remission can be extended by repeated dilatation with larger size balloon...